Carcinogenic and therapeutic role of High-Mobility Group Box 1 in Cancer: is it a cancer facilitator, a cancer inhibitor or both? WCRJ 2017; 4 (3) : e919 DOI: 10.32113/wcrj_20179_919
New insight in melanoma studies from the zebrafish animal model WCRJ 2017; 4 (1) : e843 DOI: 10.32113/wcrj_20173_843
Production of antibodies against HER2 and HER3 receptors in breast cancer treatment and the superior effect of the synchronous blockade of these receptors WCRJ 2016; 3 (4) : e810 DOI: 10.32113/wcrj_201612_810
Cancer cell growth promotion by NDPKA/nm23 H1 proportional to phosphate ion book keeping and role of estrogen receptor WCRJ 2015; 2 (3) : e550